Literature DB >> 21724622

AKT signalling in the failing heart.

Antoine H Chaanine1, Roger J Hajjar.   

Abstract

AKT is a serine/threonine protein kinase, also known as protein kinase B, which regulates cardiac growth, myocardial angiogenesis, glucose metabolism, and cell death in cardiac myocytes. AKT is activated by its phosphorylation at Thr 308 and ser 473 by PDK1 and mTORC2, respectively, in response to trophic stimuli such as insulin and insulin growth factor. c-Jun N-Terminal Kinases (JNKs) phosphorylate AKT at Thr 450 and potentiate its interaction with its downstream effectors. The short-term activation of AKT promotes physiological hypertrophy and protection from myocardial injury; whereas, its long-term activation causes pathological hypertrophy and heart failure. In this review we will discuss the role of AKT in regulating signalling pathways in the heart with special emphasis on the role of AKT in modulating stress induced autophagic cell death in cardiomyocytes in vitro.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724622      PMCID: PMC3143831          DOI: 10.1093/eurjhf/hfr080

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  45 in total

Review 1.  Role of Akt signaling in vascular homeostasis and angiogenesis.

Authors:  Ichiro Shiojima; Kenneth Walsh
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

Review 2.  Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival.

Authors:  Takashi Matsui; Tomohisa Nagoshi; Anthony Rosenzweig
Journal:  Cell Cycle       Date:  2003 May-Jun       Impact factor: 4.534

3.  Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro.

Authors:  T Matsui; L Li; Y Fukui; T F Franke; R J Hajjar; A Rosenzweig
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

4.  Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo.

Authors:  T Matsui; J Tao; F del Monte; K H Lee; L Li; M Picard; T L Force; T F Franke; R J Hajjar; A Rosenzweig
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

5.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice.

Authors:  H Cho; J L Thorvaldsen; Q Chu; F Feng; M J Birnbaum
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

7.  Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.

Authors:  David J Whellan; Christopher M O'Connor; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston-Miller; Jerome L Fleg; Kevin A Schulman; Ileana L Piña
Journal:  Am Heart J       Date:  2007-02       Impact factor: 4.749

8.  Akt signaling mediates postnatal heart growth in response to insulin and nutritional status.

Authors:  Ichiro Shiojima; Mikkael Yefremashvili; Zhengyu Luo; Yasuko Kureishi; Akihiro Takahashi; Jingzang Tao; Anthony Rosenzweig; C Ronald Kahn; E Dale Abel; Kenneth Walsh
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

Review 9.  Metabolic myopathy in heart failure.

Authors:  Renée Ventura-Clapier; Elvira De Sousa; Vladimir Veksler
Journal:  News Physiol Sci       Date:  2002-10

10.  Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth.

Authors:  Yoshiaki Taniyama; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

View more
  84 in total

Review 1.  Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-02-11

2.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Authors:  Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

3.  Over-expression of JAZF1 promotes cardiac microvascular endothelial cell proliferation and angiogenesis via activation of the Akt signaling pathway in rats with myocardial ischemia-reperfusion.

Authors:  Jie Shang; Zhi-Yong Gao; Li-Yan Zhang; Chun-Yu Wang
Journal:  Cell Cycle       Date:  2019-06-18       Impact factor: 4.534

4.  It's all in the timing: modeling isovolumic contraction through development and disease with a dynamic dual electromechanical bioreactor system.

Authors:  Kathy Ye Morgan; Lauren Deems Black
Journal:  Organogenesis       Date:  2014-10-31       Impact factor: 2.500

5.  Cardiospecific deletion of αE-catenin leads to heart failure and lethality in mice.

Authors:  Volodymyr V Balatskyi; Larysa L Macewicz; Ana-Maria Gan; Sergii V Goncharov; Paulina Pawelec; Georgiy V Portnichenko; Tetiana Yu Lapikova-Bryginska; Viktor O Navrulin; Victor E Dosenko; Adam Olichwier; Pawel Dobrzyn; Oksana O Piven
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

6.  Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.

Authors:  Zhou-Yan Bian; Xiang Wei; Shan Deng; Qi-Zhu Tang; Jinghua Feng; Yan Zhang; Chen Liu; Ding-Sheng Jiang; Ling Yan; Lian-Feng Zhang; Manyin Chen; John Fassett; Yingjie Chen; You-Wen He; Qinglin Yang; Peter P Liu; Hongliang Li
Journal:  J Mol Med (Berl)       Date:  2012-02-25       Impact factor: 4.599

7.  Primary proteasome inhibition results in cardiac dysfunction.

Authors:  Joerg Herrmann; Christine Wohlert; Ardan M Saguner; Ana Flores; Lisa L Nesbitt; Alejandro Chade; Lilach O Lerman; Amir Lerman
Journal:  Eur J Heart Fail       Date:  2013-04-24       Impact factor: 15.534

Review 8.  Vagal stimulation in heart failure.

Authors:  Gaetano M De Ferrari
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

9.  Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs.

Authors:  Kathy Ye Morgan; Lauren Deems Black
Journal:  Tissue Eng Part A       Date:  2014-04-07       Impact factor: 3.845

10.  TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.

Authors:  Zeena Eblimit; Sundararajah Thevananther; Saul J Karpen; Heinrich Taegtmeyer; David D Moore; Luciano Adorini; Daniel J Penny; Moreshwar S Desai
Journal:  Cardiovasc Ther       Date:  2018-08-22       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.